SlideShare a Scribd company logo
FORMULATING EFFECTIVE WRITTEN RESPONSE TO
DRUG
INFORMATION QUERIES
BY :-
VIKAS .S. KAMMAR
M PHARMACY
1 SEMESTER
PHARMACY PRACTICE
CO-ORDINATER :-
Dr. B R JAIDEV KUMAR
LECTURER
PHARMACY PRACTICE
1
INDEX
1. INTRODUCTION
2. OBJECTIVES
3. STEPS INVOLVED IN DIQ’S
4. CONCLUSION
5. REFERENCES
30-12-2020JSS COLLEGE OF PHARMACY MYSURU 2
INTRODUCTION TO DRUG INFORMATION
DEFINITION :-
 DRUG INFORMATION :- Providing Clinically relevant information on any aspect of drug, relating to
individual patients or general use of drug for population.
 DRUG INFORMATION SERVICES :- Any activity where information about drug use is transferred
and includes patient related pharmaceutical care .
30-12-2020JSS COLLEGE OF PHARMACY MYSURU 3
OBJECTIVES
 Skills required to provide drug information advice to public and health
care professionals .
 Describe systematic approach to answering drug information queries .
 Explain the nature of drug information resources .
30-12-2020JSS COLLEGE OF PHARMACY MYSURU 4
CONTINUED
 Understand the importance of identifying and interpreting evidence to
support clinical decisions.
 Recognize if the information need is fulfilled, & information is in
effective manner.
30-12-2020JSS COLLEGE OF PHARMACY MYSURU 5
STEPS INVOLVED
 Step 1 :- Obtain Requestor’ s Demographic details.
 Step 2 :- Procure background information.
 Step 3 :- Refine & categories the ultimate questions.
 Step 4 :- Develop a methodology and superintend a search
30-12-2020JSS COLLEGE OF PHARMACY MYSURU 6
 Step 5 :-Evaluate and Interpret the data.
 Step 6 :- Articulate & provide a effective response.
 Step 7 :- Follow up.
 Step 8 :- Documentation.
30-12-2020JSS COLLEGE OF PHARMACY MYSURU 7
STEP 1 :- OBTAIN REQUESTOR’ S DEMOGRAPHICS
 Details of the requestor .
 Set an deadline timing for every request .
 Failure .
30-12-2020JSS COLLEGE OF PHARMACY MYSURU 8
STEP 2 :- PROCURE CORRECT BACKGROUND
INFORMATION
Patient related Drug and diseases related
EX :-
PATIENT DEMOGRAPHICS
• AGE
• GENDER
• WEIGHT
• HEIGHT
• PMx
• SHx
EX :-
• DOSAGE REGIMEN
• CREATININE CLEARENCE
• LIVER ENZYME LEVELS
• HIT
• MHx
• LABORATORY VALUES
30-12-2020JSS COLLEGE OF PHARMACY MYSURU
9
STEP 3 :- REFINE & CATEGORIES THE ULTIMATE
QUESTIONS.
 This applies particularly to medical terminology and aspects of disease and
pathology. this information may help to refine the question and to estimate
the time required to achieve an acceptable response.
30-12-2020JSS COLLEGE OF PHARMACY MYSURU
10
CONTINUED
EXAMPLES OF REQUEST CATEGORIES INCLUDE :-
 Availability of dosage forms, Adverse effects, Dietary suppléments, Dosage,
Drug interactions, Extemporanés compounding, General product
information, international drugs, pharmacokinetics, teratogenicity,
therapeutics, toxicology, and veterinary medicine.
30-12-2020JSS COLLEGE OF PHARMACY MYSURU 11
STEP 4 :- DEVELOP A METHODOLOGY AND
SUPERINTEND A SEARCH
 Stepwise approaches are involved
Mainly involves 3 types of sources for search
Secondary sources
Primary sources
Tertiary sources
30-12-2020
JSS COLLEGE OF PHARMACY MYSURU
12
PRIMARY SOURCES
 JOURNALS .
 British medical journal
 New England journal
 IJPP
 AJPP
 THESIS
SECONDARY SOURCES
 MEDLINE
 CHEMICALABSTRACTS.
 DRUGDEX
 PUBMED , GOOGLE
SCHOLAR
 POISIONDEX
 INTERNATIONAL
PHARAMAABSTRACTS
30-12-2020JSS COLLEGE OF PHARMACY MYSURU 13
CONTINUED
TERTIARY SOURCES
 PHARMACOPIEAS
 USP
 BP
 IP
 DICTIONARIES
 GUIDES
 TEXTBOOK
 MERCK INDEX, MERCK MANUALS
 BNF , AUSTRALIAN FORMULARY
 HANDBOOK OF INJECTABLES
30-12-2020JSS COLLEGE OF PHARMACY MYSURU 14
Step 5 :-Evaluate and Interpret the data.
 The information gathered should be critically evaluated .
 The pharmacist should confirm information with other references to
assure consistency between various resources and whether clinical
research is relevant to your population or patient specific.
30-12-2020JSS COLLEGE OF PHARMACY MYSURU 15
Step 6 :- Articulate & provide a effective response.
 Answer should be derived only after critically evaluating the data obtained
during search.
 Clearly inform requestor when one course of drug action is desirable then
the alternative action of drug.
 All the details filled should be consisted and justified clearly & should be
prepared for additional questions.
30-12-2020
JSS COLLEGE OF PHARMACY MYSURU
16
CONTINUED
 Provide response to requestor in timely manner.
 Response can be provided any mode desired by the requestor , Mainly-
 Good verbal Communication skill & confident response should be given .
Written response
Telephone response
Urgent response
30-12-2020JSS COLLEGE OF PHARMACY MYSURU
17
STEP 7:- FOLLOW UP
 Perform a follow-up assessment to determine the utility of the information
provided.
 And whether the information resulted in changes in medication-use practices
or patient outcomes.
 Feedback
30-12-2020
JSS COLLEGE OF PHARMACY MYSURU
18
STEP 8:- DOCUMENTATION
Simple form , log book , computer programmes , worksheet can be used for
documentation.
Documentation includes :-
• Searched materials.
• Patient findings.
• Follow up reports.
• Ultimate questions.
30-12-2020JSS COLLEGE OF PHARMACY MYSURU 19
20
CONCLUSION
 A DI pharmacist has to access resources & skills requires to make best use of
available knowledge.
 It draws together a wide range of information resources and the knowledge
experience of a specialist pharmacist makes overall services more valuable than its
individual components.
30-12-2020JSS COLLEGE OF PHARMACY MYSURU 21
REFERENCES
 DRUG INFORMATION—THE SYSTEMATIC APPROACH: CONTINUING EDUCATION
ARTICLE BY JOSEPH P. NATHAN, MS, PHARMD JOURNAL OF PHARMACY
PRACTICE 26(2) 78-84. (DOI:10.1177/0897190012474229)
 CHAUHAN N:INDIAN ASPECTS OF DRUG INFORMATION RESOURCES & IMPACT OF
DIC ON COMMUNITY, J. ADV. PHARM. TECH.
 ASHP GUIDELINES ON THE PHARMACIST’S ROLE IN PROVIDING DRUG
INFORMATION BY SHADI GHAIBI, HEATHER IPEMA, AND MICHAEL GABAY AM J
HEALTH-SYST PHARM. 2015; 72:573-7
 SLIDE SHARES OF DRUGS & POISON INFORMATION BY M.G.RAJANANDH, SRM
COLLEGE OF PHARMACY, SRM UNIVERSITY.
 A TEXTBOOK OF CLINICAL PHARMACY PRACTICE SECOND EDITION , EDITOR G
PARTHASARTHI , KARIN NYFORT-HANSEN . MILAP C NAHATA
30-12-2020JSS COLLEGE OF PHARMACY MYSURU 22
THANK YOU
30-12-2020JSS COLLEGE OF PHARMACY MYSURU 23

More Related Content

What's hot

Drug Utilization research
Drug Utilization researchDrug Utilization research
Drug Utilization research
dineshmeena53
 
Essential drug concept and rational use of medicines
Essential drug concept and rational use of medicinesEssential drug concept and rational use of medicines
Essential drug concept and rational use of medicines
Pravin Prasad
 
Drug utilization studies
Drug utilization studiesDrug utilization studies
Drug utilization studies
Dr Renju Ravi
 
DIA China 2017 Optimizing Clinical Trials with Advanced Tools
DIA China 2017 Optimizing Clinical Trials with Advanced ToolsDIA China 2017 Optimizing Clinical Trials with Advanced Tools
DIA China 2017 Optimizing Clinical Trials with Advanced Tools
E. Dennis Bashaw
 
Basic Information About MBBS Course in Bangladesh http://www.mbbsbangladesh.com/
Basic Information About MBBS Course in Bangladesh http://www.mbbsbangladesh.com/Basic Information About MBBS Course in Bangladesh http://www.mbbsbangladesh.com/
Basic Information About MBBS Course in Bangladesh http://www.mbbsbangladesh.com/
Sumon Chaudhury
 
Drug utilisation studies
Drug utilisation studiesDrug utilisation studies
Drug utilisation studies
DrSiddhartha Patowary
 
Phase 0 & i clinical trial designing,conduct &challenges
Phase 0 & i clinical trial designing,conduct &challengesPhase 0 & i clinical trial designing,conduct &challenges
Phase 0 & i clinical trial designing,conduct &challenges
DrSatyabrataSahoo
 
Irrational drug use
Irrational drug useIrrational drug use
Irrational drug use
GismallaPatrice
 
Introduction to rational use of drugs and role of pharmacist in rational use...
Introduction to  rational use of drugs and role of pharmacist in rational use...Introduction to  rational use of drugs and role of pharmacist in rational use...
Introduction to rational use of drugs and role of pharmacist in rational use...
Adhin Antony Xavier
 
Pharmacoepidemiology and Pharmacoeconomics- Drug Use Measurements
Pharmacoepidemiology and Pharmacoeconomics- Drug Use MeasurementsPharmacoepidemiology and Pharmacoeconomics- Drug Use Measurements
Pharmacoepidemiology and Pharmacoeconomics- Drug Use Measurements
AnjaliBodapunti
 
Drug Utilization Studies
Drug Utilization StudiesDrug Utilization Studies
Drug Utilization Studies
Zarrin Ansari
 
Rational drug use
Rational drug useRational drug use
Rational drug use
GismallaPatrice
 
Clinical drug design
Clinical drug designClinical drug design
Clinical drug design
Prof. Dr. Basavaraj Nanjwade
 
Rational use of medicine
Rational use of medicineRational use of medicine
Rational use of medicine
Muhammad Arsal
 
Drug Utilization Studies
Drug Utilization StudiesDrug Utilization Studies
Drug Utilization Studies
VedvyasMishra1
 
Ethical practice and rational use
Ethical practice and rational useEthical practice and rational use
Ethical practice and rational use
MeTApresents
 
Rational drug therapy
Rational drug therapyRational drug therapy
Rational drug therapy
Kiran Sharma
 
Rational use of medicines for BPH
Rational use of medicines for BPHRational use of medicines for BPH
Rational use of medicines for BPH
Pravin Prasad
 
Diabetic Presentation Corrected
Diabetic Presentation CorrectedDiabetic Presentation Corrected
Diabetic Presentation Corrected
Nani Karnam Vinayakam
 
8. pharmacotherapy
8. pharmacotherapy8. pharmacotherapy
8. pharmacotherapy
Gerika Aura
 

What's hot (20)

Drug Utilization research
Drug Utilization researchDrug Utilization research
Drug Utilization research
 
Essential drug concept and rational use of medicines
Essential drug concept and rational use of medicinesEssential drug concept and rational use of medicines
Essential drug concept and rational use of medicines
 
Drug utilization studies
Drug utilization studiesDrug utilization studies
Drug utilization studies
 
DIA China 2017 Optimizing Clinical Trials with Advanced Tools
DIA China 2017 Optimizing Clinical Trials with Advanced ToolsDIA China 2017 Optimizing Clinical Trials with Advanced Tools
DIA China 2017 Optimizing Clinical Trials with Advanced Tools
 
Basic Information About MBBS Course in Bangladesh http://www.mbbsbangladesh.com/
Basic Information About MBBS Course in Bangladesh http://www.mbbsbangladesh.com/Basic Information About MBBS Course in Bangladesh http://www.mbbsbangladesh.com/
Basic Information About MBBS Course in Bangladesh http://www.mbbsbangladesh.com/
 
Drug utilisation studies
Drug utilisation studiesDrug utilisation studies
Drug utilisation studies
 
Phase 0 & i clinical trial designing,conduct &challenges
Phase 0 & i clinical trial designing,conduct &challengesPhase 0 & i clinical trial designing,conduct &challenges
Phase 0 & i clinical trial designing,conduct &challenges
 
Irrational drug use
Irrational drug useIrrational drug use
Irrational drug use
 
Introduction to rational use of drugs and role of pharmacist in rational use...
Introduction to  rational use of drugs and role of pharmacist in rational use...Introduction to  rational use of drugs and role of pharmacist in rational use...
Introduction to rational use of drugs and role of pharmacist in rational use...
 
Pharmacoepidemiology and Pharmacoeconomics- Drug Use Measurements
Pharmacoepidemiology and Pharmacoeconomics- Drug Use MeasurementsPharmacoepidemiology and Pharmacoeconomics- Drug Use Measurements
Pharmacoepidemiology and Pharmacoeconomics- Drug Use Measurements
 
Drug Utilization Studies
Drug Utilization StudiesDrug Utilization Studies
Drug Utilization Studies
 
Rational drug use
Rational drug useRational drug use
Rational drug use
 
Clinical drug design
Clinical drug designClinical drug design
Clinical drug design
 
Rational use of medicine
Rational use of medicineRational use of medicine
Rational use of medicine
 
Drug Utilization Studies
Drug Utilization StudiesDrug Utilization Studies
Drug Utilization Studies
 
Ethical practice and rational use
Ethical practice and rational useEthical practice and rational use
Ethical practice and rational use
 
Rational drug therapy
Rational drug therapyRational drug therapy
Rational drug therapy
 
Rational use of medicines for BPH
Rational use of medicines for BPHRational use of medicines for BPH
Rational use of medicines for BPH
 
Diabetic Presentation Corrected
Diabetic Presentation CorrectedDiabetic Presentation Corrected
Diabetic Presentation Corrected
 
8. pharmacotherapy
8. pharmacotherapy8. pharmacotherapy
8. pharmacotherapy
 

Similar to Modified system of DIQs

Clinical pharmacy ppt
Clinical pharmacy pptClinical pharmacy ppt
Clinical pharmacy ppt
Nabi Hasan
 
Medication Adherence
Medication Adherence Medication Adherence
Medication Adherence
sunayanamali
 
Clinical pharmacy complete notes
Clinical pharmacy complete notesClinical pharmacy complete notes
Clinical pharmacy complete notes
Ghulam Murtaza Hamad
 
Lecture 5_Managing People & Pharmacy Operations (PART II to III) (1).pdf
Lecture 5_Managing People & Pharmacy Operations (PART II to III) (1).pdfLecture 5_Managing People & Pharmacy Operations (PART II to III) (1).pdf
Lecture 5_Managing People & Pharmacy Operations (PART II to III) (1).pdf
laonedikgang1
 
Unit 3 drug utilization research (6hrs) march 12 2021
Unit 3 drug utilization research (6hrs) march 12 2021Unit 3 drug utilization research (6hrs) march 12 2021
Unit 3 drug utilization research (6hrs) march 12 2021
University of Gondar
 
Pharmacoepidemiology
Pharmacoepidemiology Pharmacoepidemiology
Pharmacoepidemiology
ashutosh mahale
 
Patient safety
Patient safetyPatient safety
Patient safety
Mahmoud Shaqria
 
EVIDENCE-BASED PSYCHIATRIC NURSING PRACTICE
EVIDENCE-BASED PSYCHIATRIC NURSING PRACTICEEVIDENCE-BASED PSYCHIATRIC NURSING PRACTICE
EVIDENCE-BASED PSYCHIATRIC NURSING PRACTICE
selvaraj227
 
Aggregate Reporting_Pharmacovigilance_Katalyst HLS
Aggregate Reporting_Pharmacovigilance_Katalyst HLSAggregate Reporting_Pharmacovigilance_Katalyst HLS
Aggregate Reporting_Pharmacovigilance_Katalyst HLS
Katalyst HLS
 
PT-781_18601919115_2..pptxmngfdcfg feefgr
PT-781_18601919115_2..pptxmngfdcfg feefgrPT-781_18601919115_2..pptxmngfdcfg feefgr
PT-781_18601919115_2..pptxmngfdcfg feefgr
KoushikPaul53
 
aggregatereportingpvkatalysthls-170327013344.pdf
aggregatereportingpvkatalysthls-170327013344.pdfaggregatereportingpvkatalysthls-170327013344.pdf
aggregatereportingpvkatalysthls-170327013344.pdf
dabloosaha
 
LITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptxLITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptx
Haramaya University
 
Intentional re-challenge and the clinical data management of Drug Related pro...
Intentional re-challenge and the clinical data management of Drug Related pro...Intentional re-challenge and the clinical data management of Drug Related pro...
Intentional re-challenge and the clinical data management of Drug Related pro...
ClinosolIndia
 
MNM COVID-19 Study
MNM COVID-19 StudyMNM COVID-19 Study
MNM COVID-19 Study
Michael Fritz
 
Medication Errors.pptx
Medication Errors.pptxMedication Errors.pptx
Medication Errors.pptx
mousaderhem1
 
[000012]
[000012][000012]
[000012]
Jatin Nagar
 
Role of Social Media in Pharmacovigilance: Challenges and Opportunities
Role of Social Media in Pharmacovigilance: Challenges and OpportunitiesRole of Social Media in Pharmacovigilance: Challenges and Opportunities
Role of Social Media in Pharmacovigilance: Challenges and Opportunities
ClinosolIndia
 
Good Pharmacovigilance Practices
Good Pharmacovigilance Practices Good Pharmacovigilance Practices
Good Pharmacovigilance Practices
sopi_1234
 
Generic Drug Shortages - Public Policy, Medicine, and Justice
Generic Drug Shortages - Public Policy, Medicine, and JusticeGeneric Drug Shortages - Public Policy, Medicine, and Justice
Generic Drug Shortages - Public Policy, Medicine, and Justice
Toyin L. Ola
 
Hospital Formulary
Hospital FormularyHospital Formulary
Hospital Formulary
sunayanamali
 

Similar to Modified system of DIQs (20)

Clinical pharmacy ppt
Clinical pharmacy pptClinical pharmacy ppt
Clinical pharmacy ppt
 
Medication Adherence
Medication Adherence Medication Adherence
Medication Adherence
 
Clinical pharmacy complete notes
Clinical pharmacy complete notesClinical pharmacy complete notes
Clinical pharmacy complete notes
 
Lecture 5_Managing People & Pharmacy Operations (PART II to III) (1).pdf
Lecture 5_Managing People & Pharmacy Operations (PART II to III) (1).pdfLecture 5_Managing People & Pharmacy Operations (PART II to III) (1).pdf
Lecture 5_Managing People & Pharmacy Operations (PART II to III) (1).pdf
 
Unit 3 drug utilization research (6hrs) march 12 2021
Unit 3 drug utilization research (6hrs) march 12 2021Unit 3 drug utilization research (6hrs) march 12 2021
Unit 3 drug utilization research (6hrs) march 12 2021
 
Pharmacoepidemiology
Pharmacoepidemiology Pharmacoepidemiology
Pharmacoepidemiology
 
Patient safety
Patient safetyPatient safety
Patient safety
 
EVIDENCE-BASED PSYCHIATRIC NURSING PRACTICE
EVIDENCE-BASED PSYCHIATRIC NURSING PRACTICEEVIDENCE-BASED PSYCHIATRIC NURSING PRACTICE
EVIDENCE-BASED PSYCHIATRIC NURSING PRACTICE
 
Aggregate Reporting_Pharmacovigilance_Katalyst HLS
Aggregate Reporting_Pharmacovigilance_Katalyst HLSAggregate Reporting_Pharmacovigilance_Katalyst HLS
Aggregate Reporting_Pharmacovigilance_Katalyst HLS
 
PT-781_18601919115_2..pptxmngfdcfg feefgr
PT-781_18601919115_2..pptxmngfdcfg feefgrPT-781_18601919115_2..pptxmngfdcfg feefgr
PT-781_18601919115_2..pptxmngfdcfg feefgr
 
aggregatereportingpvkatalysthls-170327013344.pdf
aggregatereportingpvkatalysthls-170327013344.pdfaggregatereportingpvkatalysthls-170327013344.pdf
aggregatereportingpvkatalysthls-170327013344.pdf
 
LITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptxLITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptx
 
Intentional re-challenge and the clinical data management of Drug Related pro...
Intentional re-challenge and the clinical data management of Drug Related pro...Intentional re-challenge and the clinical data management of Drug Related pro...
Intentional re-challenge and the clinical data management of Drug Related pro...
 
MNM COVID-19 Study
MNM COVID-19 StudyMNM COVID-19 Study
MNM COVID-19 Study
 
Medication Errors.pptx
Medication Errors.pptxMedication Errors.pptx
Medication Errors.pptx
 
[000012]
[000012][000012]
[000012]
 
Role of Social Media in Pharmacovigilance: Challenges and Opportunities
Role of Social Media in Pharmacovigilance: Challenges and OpportunitiesRole of Social Media in Pharmacovigilance: Challenges and Opportunities
Role of Social Media in Pharmacovigilance: Challenges and Opportunities
 
Good Pharmacovigilance Practices
Good Pharmacovigilance Practices Good Pharmacovigilance Practices
Good Pharmacovigilance Practices
 
Generic Drug Shortages - Public Policy, Medicine, and Justice
Generic Drug Shortages - Public Policy, Medicine, and JusticeGeneric Drug Shortages - Public Policy, Medicine, and Justice
Generic Drug Shortages - Public Policy, Medicine, and Justice
 
Hospital Formulary
Hospital FormularyHospital Formulary
Hospital Formulary
 

Recently uploaded

K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Kanhu Charan
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public HealthAgeing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
phuakl
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
Gokuldas Hospital
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
Dr. Sumit KUMAR
 
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
PVI, PeerView Institute for Medical Education
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
MuhammadMuneer49
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
Chulalongkorn Allergy and Clinical Immunology Research Group
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
ShraddhaTamshettiwar
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
AyushGadhvi1
 

Recently uploaded (20)

K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public HealthAgeing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
 
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfPollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
 

Modified system of DIQs

  • 1. FORMULATING EFFECTIVE WRITTEN RESPONSE TO DRUG INFORMATION QUERIES BY :- VIKAS .S. KAMMAR M PHARMACY 1 SEMESTER PHARMACY PRACTICE CO-ORDINATER :- Dr. B R JAIDEV KUMAR LECTURER PHARMACY PRACTICE 1
  • 2. INDEX 1. INTRODUCTION 2. OBJECTIVES 3. STEPS INVOLVED IN DIQ’S 4. CONCLUSION 5. REFERENCES 30-12-2020JSS COLLEGE OF PHARMACY MYSURU 2
  • 3. INTRODUCTION TO DRUG INFORMATION DEFINITION :-  DRUG INFORMATION :- Providing Clinically relevant information on any aspect of drug, relating to individual patients or general use of drug for population.  DRUG INFORMATION SERVICES :- Any activity where information about drug use is transferred and includes patient related pharmaceutical care . 30-12-2020JSS COLLEGE OF PHARMACY MYSURU 3
  • 4. OBJECTIVES  Skills required to provide drug information advice to public and health care professionals .  Describe systematic approach to answering drug information queries .  Explain the nature of drug information resources . 30-12-2020JSS COLLEGE OF PHARMACY MYSURU 4
  • 5. CONTINUED  Understand the importance of identifying and interpreting evidence to support clinical decisions.  Recognize if the information need is fulfilled, & information is in effective manner. 30-12-2020JSS COLLEGE OF PHARMACY MYSURU 5
  • 6. STEPS INVOLVED  Step 1 :- Obtain Requestor’ s Demographic details.  Step 2 :- Procure background information.  Step 3 :- Refine & categories the ultimate questions.  Step 4 :- Develop a methodology and superintend a search 30-12-2020JSS COLLEGE OF PHARMACY MYSURU 6
  • 7.  Step 5 :-Evaluate and Interpret the data.  Step 6 :- Articulate & provide a effective response.  Step 7 :- Follow up.  Step 8 :- Documentation. 30-12-2020JSS COLLEGE OF PHARMACY MYSURU 7
  • 8. STEP 1 :- OBTAIN REQUESTOR’ S DEMOGRAPHICS  Details of the requestor .  Set an deadline timing for every request .  Failure . 30-12-2020JSS COLLEGE OF PHARMACY MYSURU 8
  • 9. STEP 2 :- PROCURE CORRECT BACKGROUND INFORMATION Patient related Drug and diseases related EX :- PATIENT DEMOGRAPHICS • AGE • GENDER • WEIGHT • HEIGHT • PMx • SHx EX :- • DOSAGE REGIMEN • CREATININE CLEARENCE • LIVER ENZYME LEVELS • HIT • MHx • LABORATORY VALUES 30-12-2020JSS COLLEGE OF PHARMACY MYSURU 9
  • 10. STEP 3 :- REFINE & CATEGORIES THE ULTIMATE QUESTIONS.  This applies particularly to medical terminology and aspects of disease and pathology. this information may help to refine the question and to estimate the time required to achieve an acceptable response. 30-12-2020JSS COLLEGE OF PHARMACY MYSURU 10
  • 11. CONTINUED EXAMPLES OF REQUEST CATEGORIES INCLUDE :-  Availability of dosage forms, Adverse effects, Dietary suppléments, Dosage, Drug interactions, Extemporanés compounding, General product information, international drugs, pharmacokinetics, teratogenicity, therapeutics, toxicology, and veterinary medicine. 30-12-2020JSS COLLEGE OF PHARMACY MYSURU 11
  • 12. STEP 4 :- DEVELOP A METHODOLOGY AND SUPERINTEND A SEARCH  Stepwise approaches are involved Mainly involves 3 types of sources for search Secondary sources Primary sources Tertiary sources 30-12-2020 JSS COLLEGE OF PHARMACY MYSURU 12
  • 13. PRIMARY SOURCES  JOURNALS .  British medical journal  New England journal  IJPP  AJPP  THESIS SECONDARY SOURCES  MEDLINE  CHEMICALABSTRACTS.  DRUGDEX  PUBMED , GOOGLE SCHOLAR  POISIONDEX  INTERNATIONAL PHARAMAABSTRACTS 30-12-2020JSS COLLEGE OF PHARMACY MYSURU 13
  • 14. CONTINUED TERTIARY SOURCES  PHARMACOPIEAS  USP  BP  IP  DICTIONARIES  GUIDES  TEXTBOOK  MERCK INDEX, MERCK MANUALS  BNF , AUSTRALIAN FORMULARY  HANDBOOK OF INJECTABLES 30-12-2020JSS COLLEGE OF PHARMACY MYSURU 14
  • 15. Step 5 :-Evaluate and Interpret the data.  The information gathered should be critically evaluated .  The pharmacist should confirm information with other references to assure consistency between various resources and whether clinical research is relevant to your population or patient specific. 30-12-2020JSS COLLEGE OF PHARMACY MYSURU 15
  • 16. Step 6 :- Articulate & provide a effective response.  Answer should be derived only after critically evaluating the data obtained during search.  Clearly inform requestor when one course of drug action is desirable then the alternative action of drug.  All the details filled should be consisted and justified clearly & should be prepared for additional questions. 30-12-2020 JSS COLLEGE OF PHARMACY MYSURU 16
  • 17. CONTINUED  Provide response to requestor in timely manner.  Response can be provided any mode desired by the requestor , Mainly-  Good verbal Communication skill & confident response should be given . Written response Telephone response Urgent response 30-12-2020JSS COLLEGE OF PHARMACY MYSURU 17
  • 18. STEP 7:- FOLLOW UP  Perform a follow-up assessment to determine the utility of the information provided.  And whether the information resulted in changes in medication-use practices or patient outcomes.  Feedback 30-12-2020 JSS COLLEGE OF PHARMACY MYSURU 18
  • 19. STEP 8:- DOCUMENTATION Simple form , log book , computer programmes , worksheet can be used for documentation. Documentation includes :- • Searched materials. • Patient findings. • Follow up reports. • Ultimate questions. 30-12-2020JSS COLLEGE OF PHARMACY MYSURU 19
  • 20. 20
  • 21. CONCLUSION  A DI pharmacist has to access resources & skills requires to make best use of available knowledge.  It draws together a wide range of information resources and the knowledge experience of a specialist pharmacist makes overall services more valuable than its individual components. 30-12-2020JSS COLLEGE OF PHARMACY MYSURU 21
  • 22. REFERENCES  DRUG INFORMATION—THE SYSTEMATIC APPROACH: CONTINUING EDUCATION ARTICLE BY JOSEPH P. NATHAN, MS, PHARMD JOURNAL OF PHARMACY PRACTICE 26(2) 78-84. (DOI:10.1177/0897190012474229)  CHAUHAN N:INDIAN ASPECTS OF DRUG INFORMATION RESOURCES & IMPACT OF DIC ON COMMUNITY, J. ADV. PHARM. TECH.  ASHP GUIDELINES ON THE PHARMACIST’S ROLE IN PROVIDING DRUG INFORMATION BY SHADI GHAIBI, HEATHER IPEMA, AND MICHAEL GABAY AM J HEALTH-SYST PHARM. 2015; 72:573-7  SLIDE SHARES OF DRUGS & POISON INFORMATION BY M.G.RAJANANDH, SRM COLLEGE OF PHARMACY, SRM UNIVERSITY.  A TEXTBOOK OF CLINICAL PHARMACY PRACTICE SECOND EDITION , EDITOR G PARTHASARTHI , KARIN NYFORT-HANSEN . MILAP C NAHATA 30-12-2020JSS COLLEGE OF PHARMACY MYSURU 22
  • 23. THANK YOU 30-12-2020JSS COLLEGE OF PHARMACY MYSURU 23

Editor's Notes

  1. P SIR, NATHAN
  2. POISION & DI SLIDE SHARES